Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing since 12/18/2024, newest first.
| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Allurion Technologies, Inc.
13D/A
Amendment 13
ALURD · 02008G300
|
9.9% |
9/2/2026
Event 8/31/2026
|
|||
| RTW Investments, LP | 9.9% | ||||
| Roderick Wong | 9.9% | ||||
|
uniQure N.V.
13G
QURE · N90064101
|
5.7% |
8/14/2026
Event 6/30/2026
|
|||
| RTW Investments, LP | 5.7% | ||||
| Roderick Wong | 5.7% | ||||
|
Ultragenyx Pharmaceutical Inc.
13G
RARE · 90400D108
|
7.9% |
8/14/2026
Event 6/30/2026
|
|||
| RTW Investments, LP | 7.9% | ||||
| Roderick Wong | 7.9% | ||||
|
Tenax Therapeutics, Inc.
13G/A
Amendment 3
TENX · 88032L605
|
9.9% |
8/14/2026
Event 6/30/2026
|
|||
| RTW Investments, LP | 9.9% | ||||
| Roderick Wong | 9.9% | ||||
|
Spyre Therapeutics, Inc.
13G/A
Amendment 2
SYRE · 00773J202
|
4.8% |
8/14/2026
Event 6/30/2026
|
|||
| RTW Investments, LP | 4.8% | ||||
| Roderick Wong | 4.8% | ||||
|
RadNet, Inc.
13G/A
Amendment 1
RDNT · 750491102
|
6.2% |
8/14/2026
Event 6/30/2026
|
|||
| RTW Investments, LP | 6.2% | ||||
| Roderick Wong | 6.2% | ||||
|
Oruka Therapeutics, Inc.
13G
ORKA · 687604108
|
5.2% |
8/14/2026
Event 6/30/2026
|
|||
| RTW Investments, LP | 5.2% | ||||
| Roderick Wong | 5.2% | ||||
|
Kailera Therapeutics, Inc.
13G
KLRA · 482931102
|
8.3% |
8/14/2026
Event 6/30/2026
|
|||
| RTW Investments, LP | 8.3% | ||||
| Roderick Wong | 8.3% | ||||
|
iRhythm Holdings, Inc.
13G/A
Amendment 1
IRTC · 450056106
|
6.6% |
8/14/2026
Event 6/30/2026
|
|||
| RTW Investments, LP | 6.6% | ||||
| Roderick Wong | 6.6% | ||||
|
CG Oncology, Inc.
13G/A
Amendment 1
CGON · 156944100
|
9.7% |
8/14/2026
Event 6/30/2026
|
|||
| RTW Investments, LP | 9.7% | ||||
| Roderick Wong | 9.7% | ||||
|
Allurion Technologies, Inc.
13D/A
Amendment 12
ALURD · 02008G300
|
9.9% |
7/23/2026
Event 7/21/2026
|
|||
| RTW Investments, LP | 9.9% | ||||
| Roderick Wong | 9.9% | ||||
|
Verastem, Inc.
13G/A
Amendment 3
VSTM · 92337C203
|
9.9% |
5/15/2026
Event 3/31/2026
|
|||
| RTW Investments, LP | 9.9% | ||||
| Roderick Wong | 9.9% | ||||
|
uniQure N.V.
13G/A
Amendment 4
QURE · N90064101
|
4.1% |
5/15/2026
Event 3/31/2026
|
|||
| RTW Investments, LP | 4.1% | ||||
| Roderick Wong | 4.1% | ||||
|
Tenax Therapeutics, Inc.
13G/A
Amendment 2
TENX · 88032L605
|
9.9% |
5/15/2026
Event 3/31/2026
|
|||
| RTW Investments, LP | 9.9% | ||||
| Roderick Wong | 9.9% | ||||
|
Taysha Gene Therapies, Inc.
13G/A
Amendment 5
TSHA · 877619106
|
7.0% |
5/15/2026
Event 3/31/2026
|
|||
| RTW Investments, LP | 7.0% | ||||
| Roderick Wong | 7.0% | ||||
|
Tango Therapeutics, Inc.
13G
TNGX · 87583X109
|
9.3% |
5/15/2026
Event 3/31/2026
|
|||
| RTW Investments, LP | 9.3% | ||||
| Roderick Wong | 9.3% | ||||
|
Stoke Therapeutics, Inc.
13G/A
Amendment 7
STOK · 86150R107
|
9.9% |
5/15/2026
Event 3/31/2026
|
|||
| RTW Investments, LP | 9.9% | ||||
| Roderick Wong | 9.9% | ||||
|
Replimune Group, Inc.
13G/A
Amendment 1
REPL · 76029N106
|
8.9% |
5/15/2026
Event 3/31/2026
|
|||
| RTW Investments, LP | 8.9% | ||||
| Roderick Wong | 8.9% | ||||
|
Rapt Therapeutics, Inc.
13G/A
Amendment 2
RAPT · 75382E208
|
0% |
5/15/2026
Event 3/31/2026
|
|||
| RTW Investments, LP | 0% | ||||
| Roderick Wong | 0% | ||||
|
Milestone Pharmaceuticals Inc.
13G/A
Amendment 7
MIST · 59935V107
|
9.9% |
5/15/2026
Event 3/31/2026
|
|||
| RTW Investments, LP | 9.9% | ||||
| Roderick Wong | 9.9% | ||||
|
iRhythm Holdings, Inc.
13G
IRTC · 450056106
|
5.2% |
5/15/2026
Event 3/31/2026
|
|||
| RTW Investments, LP | 5.2% | ||||
| Roderick Wong | 5.2% | ||||
|
Immatics N.V.
13G/A
Amendment 4
IMTX · N44445109
|
9.6% |
5/15/2026
Event 3/31/2026
|
|||
| RTW Investments, LP | 9.6% | ||||
| Roderick Wong | 9.6% | ||||
|
Erasca, Inc.
13G
ERAS · 29479A108
|
5.2% |
5/15/2026
Event 3/31/2026
|
|||
| RTW Investments, LP | 5.2% | ||||
| Roderick Wong | 5.2% | ||||
|
COMPASS Pathways plc
13G/A
Amendment 2
CMPS · 20451W101
|
9.9% |
5/15/2026
Event 3/31/2026
|
|||
| RTW Investments, LP | 9.9% | ||||
| Roderick Wong | 9.9% | ||||
|
CG Oncology, Inc.
13G
CGON · 156944100
|
8.3% |
5/15/2026
Event 3/31/2026
|
|||
| RTW Investments, LP | 8.3% | ||||
| Roderick Wong | 8.3% | ||||
|
Century Therapeutics, Inc.
13G
IPSC · 15673T100
|
7.1% |
5/15/2026
Event 3/31/2026
|
|||
| RTW Investments, LP | 7.1% | ||||
| Roderick Wong | 7.1% | ||||
|
Celcuity Inc.
13G
CELC · 15102K100
|
6.3% |
5/15/2026
Event 3/31/2026
|
|||
| RTW Investments, LP | 6.3% | ||||
| Roderick Wong | 6.3% | ||||
|
Castle Biosciences, Inc.
13G/A
Amendment 1
CSTL · 14843C105
|
9.3% |
5/15/2026
Event 3/31/2026
|
|||
| RTW Investments, LP | 9.3% | ||||
| Roderick Wong | 9.3% | ||||
|
Candel Therapeutics, Inc.
13G
CADL · 137404109
|
8.8% |
5/15/2026
Event 3/31/2026
|
|||
| RTW Investments, LP | 8.8% | ||||
| Roderick Wong | 8.8% | ||||
|
Beta Bionics, Inc.
13G/A
Amendment 2
BBNX · 08659B102
|
4.5% |
5/15/2026
Event 3/31/2026
|
|||
| RTW Investments, LP | 4.5% | ||||
| Roderick Wong | 4.5% | ||||
|
Apellis Pharmaceuticals, Inc.
13G/A
Amendment 1
APLS · 03753U106
|
2.9% |
5/15/2026
Event 3/31/2026
|
|||
| RTW Investments, LP | 2.9% | ||||
| Roderick Wong | 2.9% | ||||
|
Orchestra Biomed Holdings, Inc.
13D/A
Amendment 7
OBIO · 68572M106
|
19.2% |
4/29/2026
Event 4/27/2026
|
|||
| RTW Investments, LP | 19.2% | ||||
| RTW Master Fund, Ltd. | 9.6% | ||||
| RTW Innovation Master Fund, Ltd. | 8.1% | ||||
| Roderick Wong | 19.2% | ||||
|
Allurion Technologies, Inc.
13D/A
Amendment 11
ALUR · 02008G201
|
39.4% |
3/2/2026
Event 2/26/2026
|
|||
| RTW Investments, LP | 39.4% | ||||
| RTW Master Fund, Ltd. | 21.0% | ||||
| RTW Innovation Master Fund, Ltd. | 16.2% | ||||
| Roderick Wong | 39.4% | ||||
|
Orchestra Biomed Holdings, Inc.
13D/A
Amendment 6
OBIO · 68572M106
|
19.7% |
2/25/2026
Event 2/23/2026
|
|||
| RTW Investments, LP | 19.7% | ||||
| RTW Master Fund, Ltd. | 10.0% | ||||
| RTW Innovation Master Fund, Ltd. | 8.4% | ||||
| Roderick Wong | 19.7% | ||||
|
Zai Lab Limited
13G
ZLAB · 98887Q104
|
6.3% |
2/17/2026
Event 12/31/2025
|
|||
| RTW Investments, LP | 6.3% | ||||
| Roderick Wong | 6.3% | ||||
|
Verastem, Inc.
13G/A
Amendment 2
VSTM · 92337C203
|
9.9% |
2/17/2026
Event 12/31/2025
|
|||
| RTW Investments, LP | 9.9% | ||||
| Roderick Wong | 9.9% | ||||
|
uniQure N.V.
13G/A
Amendment 3
QURE · N90064101
|
6.0% |
2/17/2026
Event 12/31/2025
|
|||
| RTW Investments, LP | 6.0% | ||||
| Roderick Wong | 6.0% | ||||
|
Tenax Therapeutics, Inc.
13G/A
Amendment 1
TENX · 88032L605
|
9.9% |
2/17/2026
Event 12/31/2025
|
|||
| RTW Investments, LP | 9.9% | ||||
| Roderick Wong | 9.9% | ||||
|
Taysha Gene Therapies, Inc.
13G/A
Amendment 4
TSHA · 877619106
|
8.3% |
2/17/2026
Event 12/31/2025
|
|||
| RTW Investments, LP | 8.3% | ||||
| Roderick Wong | 8.3% | ||||
|
SAB Biotherapeutics, Inc.
13G/A
Amendment 2
SABS · 78397T202
|
3.2% |
2/17/2026
Event 12/31/2025
|
|||
| RTW Investments, LP | 3.2% | ||||
| Roderick Wong | 3.2% | ||||
|
Rapt Therapeutics, Inc.
13G/A
Amendment 1
RAPT · 75382E208
|
5.9% |
2/17/2026
Event 12/31/2025
|
|||
| RTW Investments, LP | 5.9% | ||||
| Roderick Wong | 5.9% | ||||
|
RadNet, Inc.
13G
RDNT · 750491102
|
5.1% |
2/17/2026
Event 12/31/2025
|
|||
| RTW Investments, LP | 5.1% | ||||
| Roderick Wong | 5.1% | ||||
|
Protagonist Therapeutics, Inc
13G/A
Amendment 6
PTGX · 74366E102
|
8.1% |
2/17/2026
Event 12/31/2025
|
|||
| RTW Investments, LP | 8.1% | ||||
| Roderick Wong | 8.1% | ||||
|
Oruka Therapeutics, Inc.
13G/A
Amendment 1
ORKA · 687604108
|
4.3% |
2/17/2026
Event 12/31/2025
|
|||
| RTW Investments, LP | 4.3% | ||||
| Roderick Wong | 4.3% | ||||
|
Kalaris Therapeutics, Inc.
13G
KLRS · 482929106
|
5.7% |
2/17/2026
Event 12/31/2025
|
|||
| RTW Investments, LP | 5.7% | ||||
| Roderick Wong | 5.7% | ||||
|
Immatics N.V.
13G/A
Amendment 3
IMTX · N44445109
|
8.5% |
2/17/2026
Event 12/31/2025
|
|||
| RTW Investments, LP | 8.5% | ||||
| Roderick Wong | 8.5% | ||||
|
Exagen Inc.
13G/A
Amendment 6
XGN · 30068X103
|
4.9% |
2/17/2026
Event 12/31/2025
|
|||
| RTW Investments, LP | 4.9% | ||||
| Roderick Wong | 4.9% | ||||
|
Castle Biosciences, Inc.
13G
CSTL · 14843C105
|
7.2% |
2/17/2026
Event 12/31/2025
|
|||
| RTW Investments, LP | 7.2% | ||||
| Roderick Wong | 7.2% | ||||
|
Beta Bionics, Inc.
13G/A
Amendment 1
BBNX · 08659B102
|
5.7% |
2/17/2026
Event 12/31/2025
|
|||
| RTW Investments, LP | 5.7% | ||||
| Roderick Wong | 5.7% | ||||
|
Apogee Therapeutics, Inc.
13G/A
Amendment 1
APGE · 03770N101
|
4.9% |
2/17/2026
Event 12/31/2025
|
|||
| RTW Investments, LP | 4.9% | ||||
| Roderick Wong | 4.9% | ||||
|
Apellis Pharmaceuticals, Inc.
13G
APLS · 03753U106
|
6.1% |
2/17/2026
Event 12/31/2025
|
|||
| RTW Investments, LP | 6.1% | ||||
| Roderick Wong | 6.1% | ||||
|
Alector, Inc.
13G/A
Amendment 1
ALEC · 014442107
|
0% |
2/17/2026
Event 12/31/2025
|
|||
| RTW Investments, LP | 0% | ||||
| Roderick Wong | 0% | ||||
|
Akero Therapeutics, Inc.
13G/A
Amendment 4
AKRO · 00973Y108
|
0% |
2/17/2026
Event 12/31/2025
|
|||
| RTW Investments, LP | 0% | ||||
| Roderick Wong | 0% | ||||
|
Zai Lab Limited
13G/A
Amendment 1
ZLAB · 98887Q104
|
2.1% |
11/14/2025
Event 9/30/2025
|
|||
| RTW Investments, LP | 2.1% | ||||
| Roderick Wong | 2.1% | ||||
|
Xencor Inc
13G
XNCR · 98401F105
|
8.7% |
11/14/2025
Event 9/30/2025
|
|||
| RTW Investments, LP | 8.7% | ||||
| Roderick Wong | 8.7% | ||||
|
uniQure N.V.
13G/A
Amendment 2
QURE · N90064101
|
7.2% |
11/14/2025
Event 9/30/2025
|
|||
| RTW Investments, LP | 7.2% | ||||
| Roderick Wong | 7.2% | ||||
|
Replimune Group, Inc.
13G
REPL · 76029N106
|
8.2% |
11/14/2025
Event 9/30/2025
|
|||
| RTW Investments, LP | 8.2% | ||||
| Roderick Wong | 8.2% | ||||
|
Milestone Pharmaceuticals Inc.
13G/A
Amendment 6
MIST · 59935V107
|
9.9% |
11/14/2025
Event 9/30/2025
|
|||
| RTW Investments, LP | 9.9% | ||||
| Roderick Wong | 9.9% | ||||
|
Merus N.V.
13G/A
Amendment 1
MRUS · N5749R100
|
2.7% |
11/14/2025
Event 9/30/2025
|
|||
| RTW Investments, LP | 2.7% | ||||
| Roderick Wong | 2.7% | ||||
|
Immatics N.V.
13G/A
Amendment 2
IMTX · N44445109
|
7.3% |
11/14/2025
Event 9/30/2025
|
|||
| RTW Investments, LP | 7.3% | ||||
| Roderick Wong | 7.3% | ||||
|
Cargo Therapeutics, Inc.
13G/A
Amendment 3
CRGX · 14179K101
|
0% |
11/14/2025
Event 9/30/2025
|
|||
| RTW Investments, LP | 0% | ||||
| Roderick Wong | 0% | ||||
|
Aquestive Therapeutics, Inc.
13G
AQST · 03843E104
|
5.2% |
11/14/2025
Event 9/30/2025
|
|||
| RTW Investments, LP | 5.2% | ||||
| Roderick Wong | 5.2% | ||||
|
Alector, Inc.
13G
ALEC · 014442107
|
6.9% |
11/14/2025
Event 9/30/2025
|
|||
| RTW Investments, LP | 6.9% | ||||
| Roderick Wong | 6.9% | ||||
|
Acadia Pharmaceuticals Inc.
13G/A
Amendment 3
ACAD · 004225108
|
4.2% |
11/14/2025
Event 9/30/2025
|
|||
| RTW Investments, LP | 4.2% | ||||
| Roderick Wong | 4.2% | ||||
|
Allurion Technologies, Inc.
13D/A
Amendment 10
ALUR · 02008G201
|
48.1% |
11/13/2025
Event 11/11/2025
|
|||
| RTW Investments, LP | 48.1% | ||||
| RTW Master Fund, Ltd. | 25.5% | ||||
| RTW Innovation Master Fund, Ltd. | 19.8% | ||||
| Roderick Wong | 48.1% | ||||
|
Allurion Technologies, Inc.
13D/A
Amendment 9
ALUR · 02008G201
|
43.6% |
11/7/2025
Event 11/5/2025
|
|||
| RTW Investments, LP | 43.6% | ||||
| RTW Master Fund, Ltd. | 23.2% | ||||
| RTW Innovation Master Fund, Ltd. | 17.9% | ||||
| Roderick Wong | 43.6% | ||||
|
Avidity Biosciences, Inc.
13D/A
Amendment 5
RNAM · 05370A108
|
3.1% |
10/29/2025
Event 10/27/2025
|
|||
| RTW Investments, LP | 3.1% | ||||
| Roderick Wong | 3.1% | ||||
|
COMPASS Pathways plc
13G/A
Amendment 1
CMPS · 20451W101
|
9.9% |
8/14/2025
Event 6/30/2025
|
|||
| RTW Investments, LP | 9.9% | ||||
| Roderick Wong | 9.9% | ||||
|
Compass Therapeutics, Inc.
13G/A
Amendment 1
CMPS · 20451W101
|
0% |
8/14/2025
Event 6/30/2025
|
|||
| RTW Investments, LP | 0% | ||||
| Roderick Wong | 0% | ||||
|
Zai Lab Limited
13G
ZLAB · 98887Q104
|
5.1% |
8/14/2025
Event 6/30/2025
|
|||
| RTW Investments, LP | 5.1% | ||||
| Roderick Wong | 5.1% | ||||
|
Verastem, Inc.
13G/A
Amendment 1
VSTM · 92337C203
|
9.9% |
8/14/2025
Event 6/30/2025
|
|||
| RTW Investments, LP | 9.9% | ||||
| Roderick Wong | 9.9% | ||||
|
uniQure N.V.
13G/A
Amendment 1
QURE · N90064101
|
9.4% |
8/14/2025
Event 6/30/2025
|
|||
| RTW Investments, LP | 9.4% | ||||
| Roderick Wong | 9.4% | ||||
|
Taysha Gene Therapies, Inc.
13G/A
Amendment 3
TSHA · 877619106
|
9.9% |
8/14/2025
Event 6/30/2025
|
|||
| RTW Investments, LP | 9.9% | ||||
| Roderick Wong | 9.9% | ||||
|
Tarsus Pharmaceuticals, Inc.
13G/A
Amendment 5
TARS · 87650L103
|
8.1% |
8/14/2025
Event 6/30/2025
|
|||
| RTW Investments, LP | 8.1% | ||||
| Roderick Wong | 8.1% | ||||
|
Exagen Inc.
13G/A
Amendment 5
XGN · 30068X103
|
7.7% |
8/14/2025
Event 6/30/2025
|
|||
| RTW Investments, LP | 7.7% | ||||
| Roderick Wong | 7.7% | ||||
|
Compass Therapeutics, Inc.
13G/A
Amendment 1
CMPS · 20451W101
|
9.9% |
8/14/2025
Event 6/30/2025
|
|||
| RTW Investments, LP | 9.9% | ||||
| Roderick Wong | 9.9% | ||||
|
Cargo Therapeutics, Inc.
13G/A
Amendment 2
CRGX · 14179K101
|
6.4% |
8/14/2025
Event 6/30/2025
|
|||
| RTW Investments, LP | 6.4% | ||||
| Roderick Wong | 6.4% | ||||
|
Axsome Therapeutics, Inc.
13G/A
Amendment 4
AXSM · 05464T104
|
3.1% |
8/14/2025
Event 6/30/2025
|
|||
| RTW Investments, LP | 3.1% | ||||
| Roderick Wong | 3.1% | ||||
|
Akero Therapeutics, Inc.
13G/A
Amendment 3
AKRO · 00973Y108
|
7.3% |
8/14/2025
Event 6/30/2025
|
|||
| RTW Investments, LP | 7.3% | ||||
| Roderick Wong | 7.3% | ||||
|
Orchestra Biomed Holdings, Inc.
13D/A
Amendment 5
OBIO · 68572M106
|
15.4% |
8/6/2025
Event 8/4/2025
|
|||
| RTW Investments, LP | 15.4% | ||||
| RTW Master Fund, Ltd. | 8.1% | ||||
| RTW Innovation Master Fund, Ltd. | 5.7% | ||||
| Roderick Wong | 15.4% | ||||
|
Tenax Therapeutics, Inc.
13G
TENX · 88032L605
|
10.0% |
5/15/2025
Event 3/31/2025
|
|||
| RTW Investments, LP | 10.0% | ||||
| Roderick Wong, M.D. | 10.0% | ||||
|
89bio, Inc.
13G/A
Amendment 2
ETNB · 282559103
|
1.3% |
5/15/2025
Event 3/31/2025
|
|||
| RTW Investments, LP | 1.3% | ||||
| Roderick Wong, M.D. | 1.3% | ||||
|
GH Research PLC
13G/A
Amendment 1
GHRS · G3855L106
|
8.9% |
5/15/2025
Event 3/31/2025
|
|||
| RTW Investments, LP | 8.9% | ||||
| Roderick Wong, M.D. | 8.9% | ||||
|
PepGen Inc.
13G/A
Amendment 1
PEPG · 713317105
|
0% |
5/15/2025
Event 3/31/2025
|
|||
| RTW Investments, LP | 0% | ||||
| Roderick Wong, M.D. | 0% | ||||
|
Dyne Therapeutics, Inc.
13G/A
Amendment 2
DYN · 26818M108
|
1.5% |
5/15/2025
Event 3/31/2025
|
|||
| RTW Investments, LP | 1.5% | ||||
| Roderick Wong, M.D. | 1.5% | ||||
|
Beta Bionics, Inc.
13G
BBNX · 08659B102
|
7.6% |
5/15/2025
Event 3/31/2025
|
|||
| RTW Investments, LP | 7.6% | ||||
| Roderick Wong, M.D. | 7.6% | ||||
|
Axsome Therapeutics, Inc.
13G/A
Amendment 3
AXSM · 05464T104
|
6.0% |
5/15/2025
Event 3/31/2025
|
|||
| RTW Investments, LP | 6.0% | ||||
| Roderick Wong, M.D. | 6.0% | ||||
|
Verastem, Inc.
13G
VSTM · 92337C203
|
8.3% |
5/15/2025
Event 3/31/2025
|
|||
| RTW Investments, LP | 8.3% | ||||
| Roderick Wong, M.D. | 8.3% | ||||
|
Immunic, Inc.
13G/A
Amendment 4
IMUX · 4525EP101
|
1.1% |
5/15/2025
Event 3/31/2025
|
|||
| RTW Investments, LP | 1.1% | ||||
| Roderick Wong, M.D. | 1.1% | ||||
|
Taysha Gene Therapies, Inc.
13G/A
Amendment 2
TSHA · 877619106
|
10.0% |
5/15/2025
Event 3/31/2025
|
|||
| RTW Investments, LP | 10.0% | ||||
| Roderick Wong, M.D. | 10.0% | ||||
|
Oruka Therapeutics, Inc.
13G
ORKA · 687604108
|
5.2% |
5/15/2025
Event 3/31/2025
|
|||
| RTW Investments, LP | 5.2% | ||||
| Roderick Wong, M.D. | 5.2% | ||||
|
Rapt Therapeutics, Inc.
13G
RAPT · 75382E109
|
8.9% |
5/15/2025
Event 3/31/2025
|
|||
| RTW Investments, LP | 8.9% | ||||
| Roderick Wong, M.D. | 8.9% | ||||
|
uniQure N.V.
13G
QURE · N90064101
|
7.9% |
5/15/2025
Event 3/31/2025
|
|||
| RTW Investments, LP | 7.9% | ||||
| Roderick Wong, M.D. | 7.9% | ||||
|
COMPASS Pathways plc
13G
CMPS · 20451W101
|
8.3% |
5/15/2025
Event 3/31/2025
|
|||
| RTW Investments, LP | 8.3% | ||||
| Roderick Wong, M.D. | 8.3% | ||||
|
Orchestra Biomed Holdings, Inc.
13D/A
Amendment 4
OBIO · 68572M106
|
21.7% |
5/1/2025
Event 4/29/2025
|
|||
| RTW Investments, LP | 21.7% | ||||
| RTW Master Fund, Ltd. | 11.5% | ||||
| RTW Innovation Master Fund, Ltd. | 8.0% | ||||
| Roderick Wong, M.D. | 21.7% | ||||
|
Allurion Technologies, Inc.
13D/A
Amendment 8
ALUR · 02008G201
|
34.1% |
4/17/2025
Event 4/15/2025
|
|||
| RTW Investments, LP | 34.1% | ||||
| RTW Master Fund, Ltd. | 17.8% | ||||
| RTW Innovation Master Fund, Ltd. | 13.8% | ||||
| Roderick Wong, M.D. | 34.1% | ||||
|
Allurion Technologies, Inc.
13D/A
Amendment 7
ALUR · 02008G102
|
17.6% |
2/24/2025
Event 2/20/2025
|
|||
| RTW Investments, LP | 17.6% | ||||
| RTW Master Fund, Ltd. | 8.4% | ||||
| RTW Innovation Master Fund, Ltd. | 6.6% | ||||
| Roderick Wong, M.D. | 17.6% | ||||
|
Stoke Therapeutics, Inc.
13G/A
Amendment 6
STOK · 86150R107
|
10.0% |
2/14/2025
Event 12/31/2024
|
|||
| RTW Investments, LP | 10.0% | ||||
| Roderick Wong, M.D. | 10.0% | ||||
|
Akero Therapeutics, Inc.
13G/A
Amendment 2
AKRO · 00973Y108
|
9.8% |
2/14/2025
Event 12/31/2024
|
|||
| RTW Investments, LP | 9.8% | ||||
| Roderick Wong, M.D. | 9.8% | ||||
|
Acadia Pharmaceuticals Inc.
13G/A
Amendment 2
ACAD · 004225108
|
5.2% |
2/14/2025
Event 12/31/2024
|
|||
| RTW Investments, LP | 5.2% | ||||
| Roderick Wong, M.D. | 5.2% | ||||